| Sylvia Thomas White, LPC-MHSP, RD, LDN | |
|
3025 Kate Bond Rd, Bartlett, TN 38133 | |
| (901) 384-0065 | |
| (901) 266-1165 |
| Full Name | Sylvia Thomas White |
|---|---|
| Gender | Female |
| Speciality | Dietitian, Registered |
| Location | 3025 Kate Bond Rd, Bartlett, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225247992 | NPI | - | NPPES |
| Entity Name | Skaz Holding, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669671251 PECOS PAC ID: 9234128281 Enrollment ID: O20040506001250 |
News Archive
e-Therapeutics plc today announces that the investigator-led phase I trial of ETS2101 in brain cancer will continue into 2014. Five dose escalation steps have been completed without any drug-related serious adverse events and the investigator therefore intends to enrol further patients at higher dose levels.
A team of researchers from Columbia University Medical Center, Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer's.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Overdiagnosis poses a significant threat to human health by labeling healthy people as sick and wasting resources on unnecessary care, warns Ray Moynihan, Senior Research Fellow at Bond University in Australia, in a feature published on bmj.com today.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 6 days ago
| Entity Name | Consolidated Medical Practices Of Memphis,pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508027491 PECOS PAC ID: 1759459845 Enrollment ID: O20081002000198 |
News Archive
e-Therapeutics plc today announces that the investigator-led phase I trial of ETS2101 in brain cancer will continue into 2014. Five dose escalation steps have been completed without any drug-related serious adverse events and the investigator therefore intends to enrol further patients at higher dose levels.
A team of researchers from Columbia University Medical Center, Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer's.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Overdiagnosis poses a significant threat to human health by labeling healthy people as sick and wasting resources on unnecessary care, warns Ray Moynihan, Senior Research Fellow at Bond University in Australia, in a feature published on bmj.com today.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sylvia Thomas White, LPC-MHSP, RD, LDN 3025 Kate Bond Rd, Bartlett, TN 38133-4004 Ph: (901) 384-0065 | Sylvia Thomas White, LPC-MHSP, RD, LDN 3025 Kate Bond Rd, Bartlett, TN 38133 Ph: (901) 384-0065 |
News Archive
e-Therapeutics plc today announces that the investigator-led phase I trial of ETS2101 in brain cancer will continue into 2014. Five dose escalation steps have been completed without any drug-related serious adverse events and the investigator therefore intends to enrol further patients at higher dose levels.
A team of researchers from Columbia University Medical Center, Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer's.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Overdiagnosis poses a significant threat to human health by labeling healthy people as sick and wasting resources on unnecessary care, warns Ray Moynihan, Senior Research Fellow at Bond University in Australia, in a feature published on bmj.com today.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 6 days ago